Publication | Closed Access

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

MedicineMetronomic TherapyGynecologyConventional Platinum-based ChemotherapyRelapsed Ovarian CancerCancer TreatmentOncologyRadiation OncologyGynecology OncologyIcon4/ago-ovar-2.2 TrialOvarian Cancer